Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Vinorelbine and Bevacizumab in 2nd Line NSCLC
NCT00755170Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Nov 2008
- Primary completion
- Oct 2016
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Hellenic Oncology Research Group. Started Nov 2008; status: completed.
02
Drugs
vinorelbinebevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00755170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755170.